These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10544016)

  • 1. Molecular modeling of human procathepsin E: analysis of salt-bridge interactions between propeptide and enzyme segment.
    Azim MK; Zaidi ZH
    Biochem Biophys Res Commun; 1999 Nov; 264(3):825-32. PubMed ID: 10544016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of human procathepsin K.
    LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
    Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
    Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
    J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
    Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
    Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foldase function of the cathepsin S proregion is strictly based upon its domain structure.
    Pietschmann S; Fehn M; Kaulmann G; Wenz I; Wiederanders B; Schilling K
    Biol Chem; 2002 Sep; 383(9):1453-8. PubMed ID: 12437139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insight into propeptide-protein interactions in cathepsins L and O.
    Reif MM; Mach L; Oostenbrink C
    Biochemistry; 2012 Oct; 51(43):8636-53. PubMed ID: 23009386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.
    Podobnik M; Kuhelj R; Turk V; Turk D
    J Mol Biol; 1997 Sep; 271(5):774-88. PubMed ID: 9299326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of an activation intermediate of cathepsin E.
    Ostermann N; Gerhartz B; Worpenberg S; Trappe J; Eder J
    J Mol Biol; 2004 Sep; 342(3):889-99. PubMed ID: 15342244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation processing of cathepsin H impairs recognition by its propeptide.
    Horn M; Dolecková-Maresová L; Rulísek L; Mása M; Vasiljeva O; Turk B; Gan-Erdene T; Baudys M; Mares M
    Biol Chem; 2005 Sep; 386(9):941-7. PubMed ID: 16164419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
    Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
    Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targeting.
    Kervinen J; Tobin GJ; Costa J; Waugh DS; Wlodawer A; Zdanov A
    EMBO J; 1999 Jul; 18(14):3947-55. PubMed ID: 10406799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin D propeptide: mechanism and regulation of its interaction with the catalytic core.
    Mása M; Maresová L; Vondrásek J; Horn M; Jezek J; Mares M
    Biochemistry; 2006 Dec; 45(51):15474-82. PubMed ID: 17176069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the tertiary structure of the beta-secretase zymogen.
    Chou KC; Howe WJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):702-8. PubMed ID: 11922623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
    Reis FC; Costa TF; Sulea T; Mezzetti A; Scharfstein J; Brömme D; Ménard R; Lima AP
    FEBS J; 2007 Mar; 274(5):1224-34. PubMed ID: 17298440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens.
    Tobbell DA; Middleton BJ; Raines S; Needham MR; Taylor IW; Beveridge JY; Abbott WM
    Protein Expr Purif; 2002 Mar; 24(2):242-54. PubMed ID: 11858719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the prosegment of Fasciola hepatica cathepsin L1 in folding of the catalytic domain.
    Cappetta M; Roth I; Díaz A; Tort J; Roche L
    Biol Chem; 2002; 383(7-8):1215-21. PubMed ID: 12437108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.
    Coulombe R; Grochulski P; Sivaraman J; Ménard R; Mort JS; Cygler M
    EMBO J; 1996 Oct; 15(20):5492-503. PubMed ID: 8896443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of a Cys25 -> Ala mutant of human procathepsin S elucidates enzyme-prosequence interactions.
    Kaulmann G; Palm GJ; Schilling K; Hilgenfeld R; Wiederanders B
    Protein Sci; 2006 Nov; 15(11):2619-29. PubMed ID: 17075137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of human gastric procathepsin E and cathepsin E.
    Athauda SB; Kageyama T; Takahashi T; Inoue H; Ichinose M; Ukai M; Takahashi K
    Adv Exp Med Biol; 1995; 362():201-10. PubMed ID: 8540320
    [No Abstract]   [Full Text] [Related]  

  • 20. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
    Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
    Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.